Zenith Health Care Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 841083,
    "name": "Zenith Health",
    "stock_name": "Zenith Health",
    "full_name": "Zenith Health Care Ltd",
    "name_url": "stocks-analysis/zenith-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.42",
    "chg": 0.06,
    "chgp": "1.79%",
    "dir": 1,
    "prev_price": "3.36",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530665,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE812B01026",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "15.49 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/zenith-health-841083-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenith Health Care Stock Falls to 52-Week Low of Rs.3.2 Amidst Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-stock-falls-to-52-week-low-of-rs32-amidst-weak-financial-metrics-3735617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZenithHealthCar_priceRelatedfactors_3735617.png",
        "date": "2025-11-28 11:49:47",
        "description": "Zenith Health Care, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.3.2, reflecting continued downward pressure on its stock price despite a broadly positive market environment."
      },
      {
        "title": "Why is Zenith Health falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-zenith-health-fallingrising-3708380",
        "imagepath": "",
        "date": "2025-11-17 22:37:10",
        "description": "As of 17-Nov, Zenith Health Care Ltd's stock is currently priced at 3.80, reflecting a decrease of 0.02, or 0.52%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 1.81% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, with a 37.5% drop compared to the 5-day average, suggesting a decline in investor participation. Over the past year, the stock has seen a substantial decline of 30.15%, while the broader market, represented by the Sensex, has gained 9.50%.\n\nIn the broader market context, Zenith Health's short-term performance has been notably poor compared to the Sensex, which has increased by 1.69% over the past week. This stark contrast highlights the stock's struggle to attract investor..."
      },
      {
        "title": "How has been the historical performance of Zenith Health?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-zenith-health-3694651",
        "imagepath": "",
        "date": "2025-11-12 23:49:53",
        "description": "Answer:\nThe historical performance of Zenith Health shows a fluctuating trend in its financial metrics over the years.\n\nBreakdown:\nZenith Health's net sales have seen a decline from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025, with a notable drop in March 2024 to INR 14.47 crore and INR 13.13 crore in March 2023. The total operating income followed a similar pattern, decreasing from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025. The company's total expenditure, excluding depreciation, also decreased from INR 21.90 crore in March 2022 to INR 11.24 crore in March 2025. Operating profit (PBDIT) has fluctuated, peaking at INR 0.98 crore in March 2022 and dropping to INR 0.52 crore by March 2025. Profit before tax remained stable at INR 0.28 crore in both March 2024 and March 2025, while profit after tax decreased from INR 0.31 crore in March 2022 to INR 0.07 crore in March 20..."
      },
      {
        "title": "Are Zenith Health latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zenith-health-latest-results-good-or-bad-3693192",
        "imagepath": "",
        "date": "2025-11-12 19:29:55",
        "description": "Zenith Healthcare's latest financial results for Q2 FY26 present a mixed picture. The company reported a net profit of ₹0.14 crore, a significant recovery from a loss in the previous quarter, indicating a return to profitability. This recovery was primarily driven by improved operational efficiency, with the operating margin expanding to 7.93%, marking a notable improvement from the previous quarter's negative margin.\n\nHowever, the revenue performance raises concerns. The company experienced a decline in net sales, reporting ₹2.27 crore for the quarter, which represents a 27.94% decrease compared to the previous quarter and a 25.08% decline year-on-year. This sharp revenue contraction suggests underlying operational challenges and questions about the company's market demand and competitive positioning within the pharmaceutical sector.\n\nDespite the positive movement in profitability metrics, the overall fina..."
      },
      {
        "title": "Zenith Health Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/zenith-health-care-q2-fy26-profit-recovery-masks-deeper-revenue-concerns-3690965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZenithHealthCar_quaterlyResult_3690965.png",
        "date": "2025-11-11 20:34:18",
        "description": "Zenith Healthcare Limited, a micro-cap pharmaceutical manufacturer based in Gujarat, reported a net profit of ₹0.14 crores for Q2 FY26, reversing a loss of ₹0.02 crores in the previous quarter. However, this modest recovery came against a backdrop of significant revenue contraction, with net sales declining 27.94% quarter-on-quarter to ₹2.27 crores. The company's stock, trading at ₹3.81 with a market capitalisation of ₹21.00 crores, has plunged 33.62% over the past year, reflecting investor concerns about the sustainability of its business model."
      }
    ],
    "total": 85,
    "sid": "841083",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/zenith-health-care-841083"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday February 12 2026",
      "datetime": "02-Feb-2026",
      "details": "Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Tuesday February 12 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "16-Jan-2026",
      "details": "Submission of Decleration of RTA under Regulation 74(5) of Depositories and Participants Regulation 2018.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation of closure of trading window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zenith Health Care Stock Falls to 52-Week Low of Rs.3.2 Amidst Market Underperformance

2025-11-28 11:49:47

Zenith Health Care, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.3.2, reflecting continued downward pressure on its stock price despite a broadly positive market environment.

Why is Zenith Health falling/rising?

2025-11-17 22:37:10

As of 17-Nov, Zenith Health Care Ltd's stock is currently priced at 3.80, reflecting a decrease of 0.02, or 0.52%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 1.81% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, with a 37.5% drop compared to the 5-day average, suggesting a decline in investor participation. Over the past year, the stock has seen a substantial decline of 30.15%, while the broader market, represented by the Sensex, has gained 9.50%. In the broader market context, Zenith Health's short-term performance has been notably poor compared to the Sensex, which has increased by 1.69% over the past week. This stark contrast highlights the stock's struggle to attract investor...

How has been the historical performance of Zenith Health?

2025-11-12 23:49:53

Answer: The historical performance of Zenith Health shows a fluctuating trend in its financial metrics over the years. Breakdown: Zenith Health's net sales have seen a decline from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025, with a notable drop in March 2024 to INR 14.47 crore and INR 13.13 crore in March 2023. The total operating income followed a similar pattern, decreasing from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025. The company's total expenditure, excluding depreciation, also decreased from INR 21.90 crore in March 2022 to INR 11.24 crore in March 2025. Operating profit (PBDIT) has fluctuated, peaking at INR 0.98 crore in March 2022 and dropping to INR 0.52 crore by March 2025. Profit before tax remained stable at INR 0.28 crore in both March 2024 and March 2025, while profit after tax decreased from INR 0.31 crore in March 2022 to INR 0.07 crore in March 20...

Are Zenith Health latest results good or bad?

2025-11-12 19:29:55

Zenith Healthcare's latest financial results for Q2 FY26 present a mixed picture. The company reported a net profit of ₹0.14 crore, a significant recovery from a loss in the previous quarter, indicating a return to profitability. This recovery was primarily driven by improved operational efficiency, with the operating margin expanding to 7.93%, marking a notable improvement from the previous quarter's negative margin. However, the revenue performance raises concerns. The company experienced a decline in net sales, reporting ₹2.27 crore for the quarter, which represents a 27.94% decrease compared to the previous quarter and a 25.08% decline year-on-year. This sharp revenue contraction suggests underlying operational challenges and questions about the company's market demand and competitive positioning within the pharmaceutical sector. Despite the positive movement in profitability metrics, the overall fina...

Zenith Health Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns

2025-11-11 20:34:18

Zenith Healthcare Limited, a micro-cap pharmaceutical manufacturer based in Gujarat, reported a net profit of ₹0.14 crores for Q2 FY26, reversing a loss of ₹0.02 crores in the previous quarter. However, this modest recovery came against a backdrop of significant revenue contraction, with net sales declining 27.94% quarter-on-quarter to ₹2.27 crores. The company's stock, trading at ₹3.81 with a market capitalisation of ₹21.00 crores, has plunged 33.62% over the past year, reflecting investor concerns about the sustainability of its business model.

View All News